Home
Visterra, Inc.

Visterra, Inc. Market Share Analysis for November 2025

We use our biological insight, along with structure considerations and knowledge of the biology and molecular function, to identify specific epitopes to engage.

Health > Biotechnology and Pharmaceuticals

Domainvisterrainc.com

Year Founded2007

Employees51 - 200

Annual Revenue$15M - $25M

Visterra, Inc.

Visterra, Inc. (including company regionals)

visterrainc.com

See more website traffic and engagement information

Visterra, Inc. Revenue up to November 2025 is 15M - 25M

revenue generated by Visterra, Inc. top domains

Visterra, Inc. top domains revenue over 3 years

Revenue for Visterra, Inc. top domains

visterrainc.com15M - 25M

See more with Sales Intelligence

Total visits to Visterra, Inc.'s top domains

Understand Visterra, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

visterrainc.com2.7K

See more with Sales Intelligence

Avg. visit duration in Visterra, Inc.'s top domains

Analyze Visterra, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

visterrainc.com00:05:47

See more with Sales Intelligence

Avg. pageviews on Visterra, Inc.'s top domains

See how Visterra, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

visterrainc.com3.18

See more with Sales Intelligence

Visterra, Inc. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

otsuka-us.comCompany NameOtsuka Holdings Co., Ltd.Employees> 10001HQJapan, Chiyoda-kuAnnual revenue> $1BTotal visits118KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Visterra, Inc.

These are the website technologies, by industry, used by Visterra, Inc. top domains

Widget (5)

Twemoji

Mobile (2)

Meta Viewport

Social (2)

Instagram

Advertising (1)

DoubleClick

More Technologies

8

See all

News & Signals from Visterra, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsScailyte AG partners with Visterra Inc..Scailyte partners with Visterra on biomarker discovery.

NewsOtsuka Europe acquired Visterra Inc. for $430M on Sep 1st '18.For instance, in September 2018, Otsuka Pharmaceutical Co., Ltd., a pharmaceutical company, announced the acquisition of Visterra, Inc., a clinical stage biotechnology company, for approximately US$ 430 million in an all-cash transaction.

NewsVisterra Inc. launched Phase 2a study of VIS410 on Nov 15th '18.Visterra, Inc., a clinical stage biotechnology company, announced today that its Phase 2a study of VIS410, a novel monoclonal antibody, demonstrated safety, tolerability and clinical activity trends in non-hospitalized patients with influenza A.